We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.
- Authors
Niebel, Dennis; Ralser‐Isselstein, Veronika; Jaschke, Kristel; Braegelmann, Christine; Bieber, Thomas; Wenzel, Joerg
- Abstract
The patient received the first dose of BNT162b2 mRNA vaccine on 27th March 2021 in accordance with local prioritization conventions. Hence, CLE patients should be encouraged to claim covid-19 vaccines once available in their country.8 Whether vector-based or mRNA-based covid-19 vaccines employ a larger risk to patients with preexisting autoimmune diseases must be addressed in further studies.
- Subjects
LUPUS erythematosus; COVID-19 vaccines; COVID-19; VACCINATION; VACCINES
- Publication
Dermatologic Therapy, 2021, Vol 34, Issue 4, p1
- ISSN
1396-0296
- Publication type
Article
- DOI
10.1111/dth.15017